Anavex Life Sciences
AVXL
$3.59
Share price
4.36%
Change (1 day)
-55.90%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $12.49 M
According to Anavex Life Sciences 's latest financial reports the company's total liabilities are $12.49 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-09-30 | $12.53 M | 22.71% |
| 2022-09-30 | $10.21 M | -5.41% |
| 2021-09-30 | $10.79 M | 47.81% |
| 2020-09-30 | $7.3 M | 44.96% |
| 2019-09-30 | $5.03 M | 29.73% |
| 2018-09-30 | $3.88 M | 8.38% |
| 2017-09-30 | $3.58 M | 12.34% |
| 2016-09-30 | $3.19 M | 19.9% |
| 2015-09-30 | $2.66 M | -62.84% |
| 2014-09-30 | $7.16 M | 150.67% |
| 2013-09-30 | $2.85 M | -1.1% |
| 2012-09-30 | $2.88 M | 114.67% |
| 2011-09-30 | $1.34 M | -59.11% |
| 2010-09-30 | $3.29 M | -22.89% |
| 2009-09-30 | $4.26 M | 85.55% |
| 2008-09-30 | $2.29 M | 397.13% |
| 2007-09-30 | $0.46 M | 1551.54% |
| 2006-09-30 | $0.02 M | 3.74% |
| 2005-09-30 | $0.02 M | 977.72% |
| 2004-09-30 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $86.3 M | 590.70% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.11 B | 818.86% | 🇺🇸 USA |
 Palatin Technologies PTN | $24.93 M | 99.59% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.97 B | 7,683.02% | 🇺🇸 USA |